Vaginal lIve Biotherapeutic RANdomized Trial

NCT06135974 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Bacterial Vaginosis

Interventions

DRUG: LC106
DRUG: LC115
DRUG: Placebo
DRUG: Metronidazole Oral

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]